Developer docs
API playgroundTry for free, no card

Search company profiles

Wellstat Therapeutics Corp.

Full company profile

uuid000aiaf

Namestring
Wellstat Therapeutics Corp.
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Wellstat Therapeutics Corporation is a privately-held, for-profit biopharmaceutical company headquartered in Rockville, Maryland, USA, with an employee count in the 51-100 range and no public-market listing. The firmographic record identifies the company under the legal name Wellstat Therapeutics Corp. and lists Samuel J. Wohlstadter as President and Chief Executive Officer. As a biopharma operating in the private clinical-stage band, the company's implied business model is therapeutic discovery and development, though no specific therapeutic area, pipeline assets, platform technology, or clinical-stage programs are disclosed in the available data.

The company maintains a web presence at wellstattherapeutics.com; however, an important data-integrity flag is that the publicly accessible site resolves to a Vietnamese-language lifestyle and wellness content blog covering topics such as relationship terminology, sexual wellness, and cultural explainers, with contextual referral links to Vietnamese sexual-wellness e-commerce retailers. This content is not consistent with a US biopharma corporate website and may represent a domain-ownership collision, a parked domain, or an unrelated occupant of the wellstattherapeutics.com hostname; investors should verify direct corporate communications rather than relying on this site for company information.

No revenue figures, funding history, partnerships, M&A activity, regulatory milestones, or product launches are documented in the source material. Customer segments, pricing, and go-to-market mechanics are similarly absent. The absence of pipeline disclosure, capital-structure data, and any named scientific or commercial leadership beyond the CEO constitutes a material information gap for any investment, partnership, or M&A diligence on this entity.

Short descriptiontext

Wellstat Therapeutics Corp. is a privately-held US biopharmaceutical company headquartered in Rockville, Maryland, with 51-100 employees and no public listing; no therapeutic pipeline, platform, or commercial products are disclosed in the available data.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGaithersburg, United States
HQ citystring
Gaithersburg
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
biopharmaceutical drugs, drug development, rare disease therapeutics, pharmaceutical research, clinical drug candidates
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Biopharmaceuticals
Social media profiles1 record
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Wellstat Therapeutics Corp. is a privately-held biopharmaceutical company engaged in pharmaceutical drug discovery and development. The firm develops therapeutic drug candidates, operating from its Rockville, Maryland headquarters with 51-100 employees. Specific named products, therapeutic areas, or pipeline candidates are not disclosed in the provided source data.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Based on its About page, Wellstat Therapeutics Corp. presents itself as a knowledge platform that publishes articles explaining internet slang, social media trends, and cultural terms. The stated mission is to provide accurate, comprehensive, and accessible explanations of trending concepts. The company's homepage and About page describe a broad editorial mission covering terms such as crush, red flag, good boy, beige flag, Karen, and related cultural concepts. However, the published articles on the site cover topics that are primarily sexual wellness in nature, including content about sex toys, sexual health, and intimate topics. No discrete named product, module, or service offering was identified in the source data — the site functions as a content-publishing platform rather than a product company.

No data
Peers7 records
TypeDirect peer
Description

Late-stage clinical biopharma developing therapeutics for rare diseases and oncology supportive care indications — comparable to Wellstat's historical focus on supportive-care and rare-disease drug development.

TypeEmerging player
Description

Clinical-stage biopharma focused on rare diseases and immunologic conditions, headquartered in the Rockville/Maryland biotech corridor — comparable in geography, size, and therapeutic focus.

3Stealth BioTherapeutics Corp.
TypeDirect peer
Description

Clinical-stage biopharma developing mitochondria-targeted therapeutics for rare metabolic and neuromuscular diseases — directly comparable to Wellstat's metabolic and mitochondrial disease development profile.

4BioElectron Technology Corporation
TypeEmerging player
Description

Mid-clinical-stage biopharma developing novel small-molecule therapies for rare mitochondrial and inflammatory diseases — comparable to Wellstat in therapeutic area and stage.

TypeDirect peer
Description

Clinical-stage biopharma acquiring and advancing rare-disease and specialty therapeutics — a comparable mid-sized, multi-asset private-to-public development model.

TypeBroad incumbent
Description

Commercial-stage biopharma with a broad portfolio of rare-disease and genetic-disease assets — relevant broader incumbent operating in overlapping therapeutic categories with Wellstat's development areas.

TypeEmerging player
Description

Clinical-stage neuroscience-focused biopharma developing therapeutics for rare neurodegenerative diseases — comparable to Wellstat's historical neuroscience and rare-disease development pipeline.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wellstat Therapeutics Corp.

Biopharmaceuticalswellstattherapeutics.com

Wellstat Therapeutics Corp. is a privately-held US biopharmaceutical company headquartered in Rockville, Maryland, with 51-100 employees and no public listing; no therapeutic pipeline, platform, or commercial products are disclosed in the available data.

What Wellstat Therapeutics Corp. does

Wellstat Therapeutics Corporation is a privately-held, for-profit biopharmaceutical company headquartered in Rockville, Maryland, USA, with an employee count in the 51-100 range and no public-market listing. The firmographic record identifies the company under the legal name Wellstat Therapeutics Corp. and lists Samuel J. Wohlstadter as President and Chief Executive Officer. As a biopharma operating in the private clinical-stage band, the company's implied business model is therapeutic discovery and development, though no specific therapeutic area, pipeline assets, platform technology, or clinical-stage programs are disclosed in the available data.

The company maintains a web presence at wellstattherapeutics.com; however, an important data-integrity flag is that the publicly accessible site resolves to a Vietnamese-language lifestyle and wellness content blog covering topics such as relationship terminology, sexual wellness, and cultural explainers, with contextual referral links to Vietnamese sexual-wellness e-commerce retailers. This content is not consistent with a US biopharma corporate website and may represent a domain-ownership collision, a parked domain, or an unrelated occupant of the wellstattherapeutics.com hostname; investors should verify direct corporate communications rather than relying on this site for company information.

No revenue figures, funding history, partnerships, M&A activity, regulatory milestones, or product launches are documented in the source material. Customer segments, pricing, and go-to-market mechanics are similarly absent. The absence of pipeline disclosure, capital-structure data, and any named scientific or commercial leadership beyond the CEO constitutes a material information gap for any investment, partnership, or M&A diligence on this entity.

Wellstat Therapeutics Corp. firmographics

Firmographics
Name
Wellstat Therapeutics Corp.
Website
https://wellstattherapeutics.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Wellstat Therapeutics Corp. is a privately-held US biopharmaceutical company headquartered in Rockville, Maryland, with 51-100 employees and no public listing; no therapeutic pipeline, platform, or commercial products are disclosed in the available data.
Ownership category
akta.pro rank

Where Wellstat Therapeutics Corp. is headquartered

Location

Headquarters

HQ city
Gaithersburg
HQ country
United States
HQ region
North America

Markets served

Wellstat Therapeutics Corp. business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Distribution channels2 records

Marketing channels2 records

Wellstat Therapeutics Corp. product offering

Product offering

Core offering

Wellstat Therapeutics Corp. is a privately-held biopharmaceutical company engaged in pharmaceutical drug discovery and development. The firm develops therapeutic drug candidates, operating from its Rockville, Maryland headquarters with 51-100 employees. Specific named products, therapeutic areas, or pipeline candidates are not disclosed in the provided source data.

Product overview

Based on its About page, Wellstat Therapeutics Corp. presents itself as a knowledge platform that publishes articles explaining internet slang, social media trends, and cultural terms. The stated mission is to provide accurate, comprehensive, and accessible explanations of trending concepts. The company's homepage and About page describe a broad editorial mission covering terms such as crush, red flag, good boy, beige flag, Karen, and related cultural concepts. However, the published articles on the site cover topics that are primarily sexual wellness in nature, including content about sex toys, sexual health, and intimate topics. No discrete named product, module, or service offering was identified in the source data — the site functions as a content-publishing platform rather than a product company.

Differentiator

Problem solved

Functional benefit

Companies that use Wellstat Therapeutics Corp.

Customer profile

Ideal customer profiles1 record

Wellstat Therapeutics Corp. technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Wellstat Therapeutics Corp. competitors and assessment

Company assessment

Direct peers

  • Soligenix, Inc. Late-stage clinical biopharma developing therapeutics for rare diseases and oncology supportive care indications — comparable to Wellstat's historical focus on supportive-care and rare-disease drug development.
  • Stealth BioTherapeutics Corp. Clinical-stage biopharma developing mitochondria-targeted therapeutics for rare metabolic and neuromuscular diseases — directly comparable to Wellstat's metabolic and mitochondrial disease development profile.
  • Mereo BioPharma Group plc: Clinical-stage biopharma acquiring and advancing rare-disease and specialty therapeutics — a comparable mid-sized, multi-asset private-to-public development model.

Emerging players

  • Cerecor Inc. Clinical-stage biopharma focused on rare diseases and immunologic conditions, headquartered in the Rockville/Maryland biotech corridor — comparable in geography, size, and therapeutic focus.
  • BioElectron Technology Corporation: Mid-clinical-stage biopharma developing novel small-molecule therapies for rare mitochondrial and inflammatory diseases — comparable to Wellstat in therapeutic area and stage.
  • Vigil Neuroscience, Inc. Clinical-stage neuroscience-focused biopharma developing therapeutics for rare neurodegenerative diseases — comparable to Wellstat's historical neuroscience and rare-disease development pipeline.

Broad incumbents

  • BridgeBio Pharma, Inc. Commercial-stage biopharma with a broad portfolio of rare-disease and genetic-disease assets — relevant broader incumbent operating in overlapping therapeutic categories with Wellstat's development areas.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights3 records

Customer concentration

Wellstat Therapeutics Corp. social profiles

Digital presence

Wellstat Therapeutics Corp. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wellstat Therapeutics Corp. leadership team

Management profile

Number of profiles

Profiles1 record

Wellstat Therapeutics Corp. funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wellstat Therapeutics Corp. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wellstat Therapeutics Corp.

What does Wellstat Therapeutics Corp. do?

Wellstat Therapeutics Corp. is a privately-held biopharmaceutical company engaged in pharmaceutical drug discovery and development. The firm develops therapeutic drug candidates, operating from its Rockville, Maryland headquarters with 51-100 employees. Specific named products, therapeutic areas, or pipeline candidates are not disclosed in the provided source data.

When was Wellstat Therapeutics Corp. founded?

Wellstat Therapeutics Corp. was founded in -1. It employs 11 to 50 people.

Where is Wellstat Therapeutics Corp. based?

Wellstat Therapeutics Corp. is headquartered in Gaithersburg, United States, in the North America region.

Who are Wellstat Therapeutics Corp.'s main competitors?

Direct peers on record are Soligenix, Inc., Stealth BioTherapeutics Corp. and Mereo BioPharma Group plc. Emerging players are Cerecor Inc., BioElectron Technology Corporation and Vigil Neuroscience, Inc.. BridgeBio Pharma, Inc. is listed as a broad incumbent.

Does Wellstat Therapeutics Corp. have an API?

No public API is recorded for Wellstat Therapeutics Corp..

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals